Receptor activity-modifying protein 3 enhances GLP-1-mediated insulin secretion.

There was a significant trend for RAMP3 to increase maximal signaling in response to all agonists ( p < 0.0001) ( Fig. 2 , E and F , Table 1 ).

also in 9,775 other papers